- Impact of Serum Leptin to Adiponectin Ratio on Regression of Metabolic Syndrome in High-Risk Individuals: The ARIRANG Study
-
Kang DR, Yadav D, Koh SB, Kim JY, Ahn SV
- KMID: 2427122
- Yonsei Med J.
- 2017 Mar;58(2):339-346.
- doi: 10.3349/ymj.2017.58.2.339
PURPOSE: The ratio of serum leptin to adiponectin (L/A ratio) could be used as a marker for insulin resistance. However, few prospective studies have investigated the impact of L/A ratio on... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study
-
Choi JR, Kim JY, Park IH, Huh JH, Kim KW, Cha SK, Park KS, Sohn JH, Park JT, Koh SB
- KMID: 2418793
- Yonsei Med J.
- 2018 Mar;59(2):287-293.
- doi: 10.3349/ymj.2018.59.2.287
PURPOSE: Fibroblast growth factor 21 (FGF21) is a crucial metabolic regulator, with multiple favorable effects on glucose homeostasis and lipid metabolism. Since serum FGF21 level has been implicated as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study
-
Yadav D, Lee MY, Kim JY, Ryu H, Huh JH, Bae KS, Ahn SV, Chung CH, Park JT, Koh SB
- KMID: 2419082
- Yonsei Med J.
- 2017 Jul;58(4):763-769.
- doi: 10.3349/ymj.2017.58.4.763
PURPOSE: Although γ-glutamyltransferase (GGT) is well known to be associated with metabolic syndrome (MS), prospective data on baseline and longitudinal changes in GGT levels and incident cases of MS are... -
- CITED
-
- Close
- SHARE
-
- Close
